Capital asset pricing model (CAPM) indicates what should be the expected or required rate of return on risky assets like Vertex Pharmaceuticals Inc. common stock.
Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Statement of Comprehensive Income
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Balance Sheet: Assets
- Analysis of Short-term (Operating) Activity Ratios
- Common Stock Valuation Ratios
- Price to FCFE (P/FCFE)
- Present Value of Free Cash Flow to Equity (FCFE)
- Total Asset Turnover since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Rates of Return
Vertex Pharmaceuticals Inc. (VRTX) | Standard & Poor’s 500 (S&P 500) | |||||
---|---|---|---|---|---|---|
t | Date | PriceVRTX,t1 | DividendVRTX,t1 | RVRTX,t2 | PriceS&P 500,t | RS&P 500,t3 |
Jan 31, 2019 | ||||||
1. | Feb 28, 2019 | |||||
2. | Mar 31, 2019 | |||||
3. | Apr 30, 2019 | |||||
. | . | . | . | . | . | . |
. | . | . | . | . | . | . |
. | . | . | . | . | . | . |
58. | Nov 30, 2023 | |||||
59. | Dec 31, 2023 | |||||
Average (R): | ||||||
Standard deviation: |
Vertex Pharmaceuticals Inc. (VRTX) | Standard & Poor’s 500 (S&P 500) | |||||
---|---|---|---|---|---|---|
t | Date | PriceVRTX,t1 | DividendVRTX,t1 | RVRTX,t2 | PriceS&P 500,t | RS&P 500,t3 |
Jan 31, 2019 | ||||||
1. | Feb 28, 2019 | |||||
2. | Mar 31, 2019 | |||||
3. | Apr 30, 2019 | |||||
4. | May 31, 2019 | |||||
5. | Jun 30, 2019 | |||||
6. | Jul 31, 2019 | |||||
7. | Aug 31, 2019 | |||||
8. | Sep 30, 2019 | |||||
9. | Oct 31, 2019 | |||||
10. | Nov 30, 2019 | |||||
11. | Dec 31, 2019 | |||||
12. | Jan 31, 2020 | |||||
13. | Feb 29, 2020 | |||||
14. | Mar 31, 2020 | |||||
15. | Apr 30, 2020 | |||||
16. | May 31, 2020 | |||||
17. | Jun 30, 2020 | |||||
18. | Jul 31, 2020 | |||||
19. | Aug 31, 2020 | |||||
20. | Sep 30, 2020 | |||||
21. | Oct 31, 2020 | |||||
22. | Nov 30, 2020 | |||||
23. | Dec 31, 2020 | |||||
24. | Jan 31, 2021 | |||||
25. | Feb 28, 2021 | |||||
26. | Mar 31, 2021 | |||||
27. | Apr 30, 2021 | |||||
28. | May 31, 2021 | |||||
29. | Jun 30, 2021 | |||||
30. | Jul 31, 2021 | |||||
31. | Aug 31, 2021 | |||||
32. | Sep 30, 2021 | |||||
33. | Oct 31, 2021 | |||||
34. | Nov 30, 2021 | |||||
35. | Dec 31, 2021 | |||||
36. | Jan 31, 2022 | |||||
37. | Feb 28, 2022 | |||||
38. | Mar 31, 2022 | |||||
39. | Apr 30, 2022 | |||||
40. | May 31, 2022 | |||||
41. | Jun 30, 2022 | |||||
42. | Jul 31, 2022 | |||||
43. | Aug 31, 2022 | |||||
44. | Sep 30, 2022 | |||||
45. | Oct 31, 2022 | |||||
46. | Nov 30, 2022 | |||||
47. | Dec 31, 2022 | |||||
48. | Jan 31, 2023 | |||||
49. | Feb 28, 2023 | |||||
50. | Mar 31, 2023 | |||||
51. | Apr 30, 2023 | |||||
52. | May 31, 2023 | |||||
53. | Jun 30, 2023 | |||||
54. | Jul 31, 2023 | |||||
55. | Aug 31, 2023 | |||||
56. | Sep 30, 2023 | |||||
57. | Oct 31, 2023 | |||||
58. | Nov 30, 2023 | |||||
59. | Dec 31, 2023 | |||||
Average (R): | ||||||
Standard deviation: |
Show all
1 Data in US$ per share of common stock, adjusted for splits and stock dividends.
2 Rate of return on common stock of VRTX during period t
3 Rate of return on S&P 500 (the market portfolio proxy) during period t
Variance and Covariance
t | Date | RVRTX,t | RS&P 500,t | (RVRTX,t–RVRTX)2 | (RS&P 500,t–RS&P 500)2 | (RVRTX,t–RVRTX)×(RS&P 500,t–RS&P 500) |
---|---|---|---|---|---|---|
1. | Feb 28, 2019 | |||||
2. | Mar 31, 2019 | |||||
3. | Apr 30, 2019 | |||||
. | . | . | . | . | . | . |
. | . | . | . | . | . | . |
. | . | . | . | . | . | . |
58. | Nov 30, 2023 | |||||
59. | Dec 31, 2023 | |||||
Total (Σ): |
t | Date | RVRTX,t | RS&P 500,t | (RVRTX,t–RVRTX)2 | (RS&P 500,t–RS&P 500)2 | (RVRTX,t–RVRTX)×(RS&P 500,t–RS&P 500) |
---|---|---|---|---|---|---|
1. | Feb 28, 2019 | |||||
2. | Mar 31, 2019 | |||||
3. | Apr 30, 2019 | |||||
4. | May 31, 2019 | |||||
5. | Jun 30, 2019 | |||||
6. | Jul 31, 2019 | |||||
7. | Aug 31, 2019 | |||||
8. | Sep 30, 2019 | |||||
9. | Oct 31, 2019 | |||||
10. | Nov 30, 2019 | |||||
11. | Dec 31, 2019 | |||||
12. | Jan 31, 2020 | |||||
13. | Feb 29, 2020 | |||||
14. | Mar 31, 2020 | |||||
15. | Apr 30, 2020 | |||||
16. | May 31, 2020 | |||||
17. | Jun 30, 2020 | |||||
18. | Jul 31, 2020 | |||||
19. | Aug 31, 2020 | |||||
20. | Sep 30, 2020 | |||||
21. | Oct 31, 2020 | |||||
22. | Nov 30, 2020 | |||||
23. | Dec 31, 2020 | |||||
24. | Jan 31, 2021 | |||||
25. | Feb 28, 2021 | |||||
26. | Mar 31, 2021 | |||||
27. | Apr 30, 2021 | |||||
28. | May 31, 2021 | |||||
29. | Jun 30, 2021 | |||||
30. | Jul 31, 2021 | |||||
31. | Aug 31, 2021 | |||||
32. | Sep 30, 2021 | |||||
33. | Oct 31, 2021 | |||||
34. | Nov 30, 2021 | |||||
35. | Dec 31, 2021 | |||||
36. | Jan 31, 2022 | |||||
37. | Feb 28, 2022 | |||||
38. | Mar 31, 2022 | |||||
39. | Apr 30, 2022 | |||||
40. | May 31, 2022 | |||||
41. | Jun 30, 2022 | |||||
42. | Jul 31, 2022 | |||||
43. | Aug 31, 2022 | |||||
44. | Sep 30, 2022 | |||||
45. | Oct 31, 2022 | |||||
46. | Nov 30, 2022 | |||||
47. | Dec 31, 2022 | |||||
48. | Jan 31, 2023 | |||||
49. | Feb 28, 2023 | |||||
50. | Mar 31, 2023 | |||||
51. | Apr 30, 2023 | |||||
52. | May 31, 2023 | |||||
53. | Jun 30, 2023 | |||||
54. | Jul 31, 2023 | |||||
55. | Aug 31, 2023 | |||||
56. | Sep 30, 2023 | |||||
57. | Oct 31, 2023 | |||||
58. | Nov 30, 2023 | |||||
59. | Dec 31, 2023 | |||||
Total (Σ): |
Show all
VarianceVRTX = Σ(RVRTX,t–RVRTX)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
VarianceS&P 500 = Σ(RS&P 500,t–RS&P 500)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
CovarianceVRTX, S&P 500 = Σ(RVRTX,t–RVRTX)×(RS&P 500,t–RS&P 500) ÷ (59 – 1)
= ÷ (59 – 1)
=
Systematic Risk (β) Estimation
VarianceVRTX | |
VarianceS&P 500 | |
CovarianceVRTX, S&P 500 | |
Correlation coefficientVRTX, S&P 5001 | |
βVRTX2 | |
αVRTX3 |
Calculations
1 Correlation coefficientVRTX, S&P 500
= CovarianceVRTX, S&P 500 ÷ (Standard deviationVRTX × Standard deviationS&P 500)
= ÷ ( × )
=
2 βVRTX
= CovarianceVRTX, S&P 500 ÷ VarianceS&P 500
= ÷
=
3 αVRTX
= AverageVRTX – βVRTX × AverageS&P 500
= – ×
=
Expected Rate of Return
Assumptions | ||
Rate of return on LT Treasury Composite1 | RF | |
Expected rate of return on market portfolio2 | E(RM) | |
Systematic risk (β) of Vertex Pharmaceuticals Inc. common stock | βVRTX | |
Expected rate of return on Vertex Pharmaceuticals Inc. common stock3 | E(RVRTX) |
1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).
3 E(RVRTX) = RF + βVRTX [E(RM) – RF]
= + [ – ]
=